NCT01679548

Study of Laparoendoscopic Single Site Hysterectomy in Benign and Preinvasive Uterine Disease

Completed NA Last updated 25 March 2024

What this trial tests

NA trial testing Single-port LAVH in Benign or Preinvasive Uterine Disease in 424 participants. Completed in 11 June 2019.

Timeline

23 November 2012

Primary endpoint
12 December 2018

11 June 2019

Quick facts

Lead sponsor	Asan Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	424
Start date	23 November 2012
Primary completion	12 December 2018
Estimated completion	11 June 2019
Sites	1 location across South Korea

Drugs / interventions tested

• Single-port LAVH
• Three-port LAVH

Conditions studied

• Benign or Preinvasive Uterine Disease — all drugs for Benign or Preinvasive Uterine Disease →

Sponsor

Asan Medical Center

Who can join

Adults 20 to 70, female only, with Benign or Preinvasive Uterine Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the efficacy between single-port and three-port laparoscopic assisted vaginal hysterectomy in patients with benign or preinvasive uterine disease

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Comparison of single-site and three-port hysterectomy for benign uterine diseases: A randomised trial (LESS-H).
   Kang OJ, Nam JH, Park JY. · · 2025 · PMID 40088545 · DOI 10.1016/j.ejogrb.2025.03.005